Manufacturer record
Nanoceut Therapeutics Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Nanoceut Therapeutics Pvt. Ltd (Puducherry) were declared Not of Standard Quality between December 2024 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Nanoceut Therapeutics Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Clopidogrel and Aspirin Capsules | ND260242Mfg 2026-01 · Exp 2027-12 | Free Salicylic acidOther | DTL, Chennai-06State lab | May 2026 |
| Atorvastatin Tablets IP 10mg | ND251642Mfg 2025-10 · Exp 2027-09 | ContentOther | DTL, Madurai-19State lab | May 2026 |
| Cefixime Trihydrate With Lactic Acid Bacillus Tablets | NTT250192Mfg 2025-01 · Exp 2026-06 | DisintegrationDisintegration | DTL, PuducherryState lab | Aug 2025 |
| Aceclofenac & Paracetamol Tablets (Aceclon-P) | NTT250578Mfg 2025-02 · Exp 2028-01 | The sample received is labelled as Aceclofenac And Paracetamol Tablets (Aceclon-P) , however Aceclofenac And Paracetamol Tablets is an official IP monograph (IP Addendum 2024) hence should be labelled as Aceclofenac And Paracetamol Tablets IPLabelling | State lab , PuducherryState lab | May 2025 |
| Orsiclop-A75 | NTT24103 6Mfg 2024-03 · Exp 2026-02 | Sample does not conform to IP specification for Clopidogrel and Aspirin Tablets with respect to Dissolution ( Clopidogrel and Aspirin), Free Salicylic Acid (Related substance for Aspirin) and to the content of ASpirinDissolution | DTL ChennaiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.